Список использованной литературы по медицине, диссертация 2004 года, Шевельчинский, Сергей Иванович

1. Андриенко В.К. Гербеев Ю.В. Невский И.А. Система перевоспитания подростков в условиях специальной школы.- Москва, 1990, 96 с.

2. Антропов Ю. Ф. Психосоматические расстройства у детей и подростков (клиника, динамика и дифференцированное лечение). Автореф. дисс. докт. мед. наук. 46 с.

3. Антропов Ю.Ф. Психическое здоровье детей и подростков // Депопуляция в России: причины, тенденции, последствия и пути выхода. М.,1996, ч.Ш. - с. 40-41.

4. Ахутина Т.В., Семаго М.М., Семаго Н.Я., Светлова Н.А., Береславская М.И. Психолого-медико-педагогическое обследование ребенка. Комплект рабочих материалов.- Москва, 1999, 134 с.

5. Ганзин И В Комплексное клинико-это лого лингвистическое исследование речевого поведения при психических расстройствах. //Украинский медицинский журнал.- 2003. Т. 33. - №1- с.5-7.

6. Глезерман Т.Б. Мозговые дисфункции у детей,- Москва, 1983, 239 с.

7. Грачев В. В. Клинические и энцефалографические проявления синдрома Ретта. Автореф. дисс. канд. мед. наук 32 с.

8. Демьянов Ю.Г. Основы пихопрофилактики.- СПб.:Паритет, 1999, 126 с.

9. Заваденко Н.Н. Петрухин А.С. Суворинова Н.Ю. Румянцева М.В. Овчинникова А.А. Возрастная динамика минимальных мозговых дисфункций.- М., РКИ Соверо-пресс, 2001.

10. Зенков JI.P. (Zenkov L.R.) Cerebral Mechanisms of Epileptic and Non-epileptic Disorders and a Knowlege-based System for Their Differential Diagnosis. Epileptologia, 1995, T.4, N4, p.348-358.

11. Зенков Л.P. Патогенез и мультипараметрическая диагностика эпилептических и неэпилептических припадков и принятие решения о про-тивоэпилептическом лечении. Часть 1. Terra medica, 1997, N4, с. 14-18.

12. Зенков Л.Р. Патогенез и мультипараметрическая диагностика эпилептических и неэпилептических припадков. Часть 2. Terra medica,1998, №1, стр.44-46.

13. Зенков Л.Р. Долгосрочные бессудорожные эпилептические статусы. В кн.: "Эпилепсия и клиническая нейрофизиология", Крым, Ялта-Гурзуф,1999, с.85-87.

14. Зенков Л.Р. Клиническая эпилептология (руководство для врачей). М. Медицинское информационное издательство. 2002. 416 с.

15. Зенков Л.Р. Клиническое значение изменений электроэнцефалограммы при лечении эпилепсии вальпроатом (Депакин хроно) // Ж. невропатологии и психиатрии.- 2002.- Т. 102.- с.20-26.

16. Зенков Л.Р. Клиническая электроэнцефалография (с элементами эпилептологии). М. Медпресс. 2002,- 358 с.

17. Л.Р.Зенков. Современное лечение эпилепсии. М. Печатный город. 2003.214 с.

18. Зенков Л.Р., Айвазян С.О., Усачева Е.Л., Харламов Д.А. Эпилепсия без припадков? Патогенез, клиника, классификация, лечение. В кн.: Эпилепсия и пароксизмальные состояния в неврологии. (24-26 сентября2001 г., г. Ступино), с. 28-33.

19. Зенков JI.P., Брикенштейн В.Х., Лукьянов В.М. и др. Программа анализа электроэнцефалографических исследований "АЛЬФА-2000". Свидетельство о регистрации № 2000620018.

20. Зенков Л.Р., Карлов В.А., Жидкова И.А. (Zenkov L.R., Karlov V.A., Zhidkova I.A.) A knowlege-based system for differential diagnosis of epileptic and nonepileptic attacs. In: 2-nd Congress Epileptologii, Warszdawa, V,1995. p. 17-20.

21. Зенков Л.Р., Карлов В.А., Ронкин M.A., Гедекова А., Камышев А.Н. Возможности диагностики и оценки риска эпилепсии по данным спектрального анализа ЭЭГ у детей и подростков. Ж. невропатол. и психиатр., 1989, т.89, в.8, с.20-22.

22. Зенков Л.Р., Притыко А.Г. Фармакорезистентные эпилепсии. М. Медпресс.- 2003.- 205 с.

23. Зенков Л.Р., Усачева Е.Л., Клишевская Л.A. (Zenkov L.R., Usachova E.L., Klishevskaja L.A.) Epileptic aphasia and mutism neuropsychophisiology and treatment. XI conference on epilepsy. Gdansk, May 23-25, 1996, p.130-131.

24. Л.Р.Зенков, С.И.Шевельчинский, Константинов П.А., Мясников В.Н., Сиразитдинова Э.Б. Бессудорожные эпилептические энцефалопатии, аутизм и другие растройства психического развития //Аутизм и нарушения развития. 2004,- №1. - с. 2-19.

25. Карлов В.А., Зенков J1.P., Гедекова А. и др. Спектральный анализ ЭЭГ у детей и подростков, страдающих эпилепсией: общие характеристики и патофизиологическая интерпретация данных. // Журн. невропатол. и психиатр., 1989, т.89, с. 15-19.

26. Клиническая психиатрия: пер. с англ. доп.// гл. ред. Т.Б. Дмитриева М.: ГЭОТАР МЕДИЦИНА, 1998. - ISBN 5-88816-010-5. Pocket Handbook of Clinical Psychiatry//Harold 1. Kaplan, Benjamin J. Sadock//Baltimore, Williams & Wilkins. - ISBN 0-683-04583-0.

27. Ковтун О.П., ЛьвоваО.А., СулимовА.В., Минимальная мозговая дисфункция у детей /Методические рекомендации.- Екатеринбург.2003

28. Корнев А.Н. Дислексия и дисграфия у детей. С-Петербург, 1995, 221 с.

29. Коробенко Н.В. Клиника и диагностика раннего детского аутизма // Аутизм и нарушения развития. 2003. - №1. - с. 2-9.

30. Корсакова Н.К., Микадзе Ю.В., Балашова Е.Ю. Неуспевающие дети: нейропсихологическая диагностика трудностей в обучении младших школьников. Москва, 1997, 123 с.

31. Мельничук П.В., Зенков Л.Р., Морозов А.А., Коган Э.И., Аверьянов Ю.Н. Нейрофизиологические механизмы афазии при эпилепсии. // Ж. невропатол. и психиатр.- 1990.- Т. 90.- с. 34-40.

32. Менделевич В.Д. Поведенческие расстройства или девиации поведения?; // Ж. Психиатрия и психофармакотерапия Т. 2/N 6/2000 с. 11-13.

33. Модели диагностики и лечения психических и поведенческих расстройств. / Под ред. проф. В.Н.Краснова и проф. И.Я.Гуровича, Московский НИИ психиатрии МЗ России. 1999. с. 82-104.

34. Патология психического развития / под. ред. академика А.С. Тиганова.-М. Научный центр психического здоровья РАМН. 1998.

35. Петрухин А.С. Нейропсихиатрические проблемы эпилепсии // Неврологический журнал.- 1999.- Т. 4.- с. 4-10.

36. Романова O.JI., Иванннкова И.В. Опыт применения программы профилактики отклоняющегося поведения для психологической коррекции "трудного класса" // Вопросы психологии.-1994.-№6, с. 6-7.

37. Рудестам К. Групповая психотерапия. М.: Прогресс, 1993. 134 с.

38. Руководство практического психолога /под ред. Дубровиной И.В. / М.,1995. 144 с.

39. Саенко Е.В. Профессиональная деятельность психолога при профилактике девиантного поведения. Автореф. дисс. канд. психол. наук. Тверь, 1995, 39 с.

40. Симерницкая Э.Г. Нейропсихологическая методика экспресс-диагностики "Лурия-90". Москва, 1991, 48 с.

41. Современные подходы к диагностике и лечению минимальных мозговых дисфункций у детей. / Методические рекомендации. Заваденко Н.Н., Петрухин А.С., Суворинова Н.Ю., Румянцева М.В., Овчинникова А.А. / -М.: Издатель Е.Разумова, 2002. 39 с.

42. Степанов В.Г. Психология трудного школьника. Москва, 1998, 78 с.

43. Ткачева В.В. Психокоррекционная работа с матерями, воспитывающими детей с проблемами в развитии. М., 2000, 38 с.

44. Усачева Е.Л., Яхно Н.Н., Зенков Л.Р., Полонская Н.Н. Когнитивные и поведенческие нарушения у детей при эпилепсии. В кн.: Притыко А.Г. (ред.). Передовые технологии лечения на стыке веков. М.2000. с. 105.

45. Чижакова Г.И., Новикова Л.А. Коррекция отклоняющегося поведения детей и подростков. Красноярск, 1997, 84 с.

46. Шевандрин Н.И. Психодиагностика, коррекция и развитие личности. -М.: Владос, 1998, 96 с.

47. Шевельчинский С.И., Мишин Н.А., Ганыч А.А., Шевельчинская С.А. Опыт применения вальпроатов у детей с расстройствами поведения. В кн.: IV Восточно-Европейская конференция «Эпилепсия и клиническая нейрофизиология». Ялта-Гурзуф 1- 6 июня 2002. с.32-34.

48. Шипицына JI.M. Иванов Е.С. Нарушения поведения учеников вспомогательной школы. Уэльс, Великобритания, 1992.- 211с.

49. Яхно Н.Н., Усачева E.JL, Зенков JI.P. (Yakhno N.N., Oussatcheva E.L., Zenkov L.R.) CNV in children with different degree of psychosocial epileptic disability. Epilepsia, 1998, v.39, suppl.2, p. 121.

50. Adrien, J. L., Barthelemy, C., Lelord, G., et al (1989) Use of bioclinical markers for the assessment and treatment of children with pervasive developmental disorders. Neuropsychobiology, 22, 117 -124.

51. Aggleton JP. The contribution of the amygdala to normal and abnormal emotional states. Trends Neurosci 1993; p.28-33

52. Aldenkamp A. The effect of epilepsy and epileptic seizures on cognitive function // Factors affecting cognitive function in epilepsy. Eurocare. UCB

53. Disease Management.- 2000.- P. 2-7.

54. Anderson GM, Freedman DX, Cohen DJ, Volkmar FR, Hoder WL, McPhedran P, Minderaa RB, Hansen CR, Young JG. Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 1987; 28: 885900.

55. Anderson GM, Schlicht KR, Cohen DJ. Two-dimensional high performance liquid chromatographic determination of 5-hydroxyindoleacetic acid and homovanillic acid in urine. Anal Biochem 1985; 144: 27-31.

56. Andy OJ, Jurko MF. Hyperresponsive syndrome. In: Hitchcock E, Laitinen L, Vaernet K, editors. Psychosurgery. Springfield (IL): Charles C. Thomas; 1972. p. 117-26.

57. R Antochil, С Stavrakakil and P С Emery2 Psychopharmacological treatments in persons with dual diagnosis of psychiatric disorders and developmental disabilities Postgraduate Medical Journal 2003;79:139-146

58. Attwood, A. & Wing, L. (1987) Syndromes of autism and atypical development. In Handbook of Autism and Pervasive Developmental Disorders (eds D.J.Cohen & A. M. Donellan), Vol. 25, pp. 3-19. New York: John Wiley & Sons.

59. Bailey, A., Phillips, W. & Rutter, M. (1996) Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives. Journal of Child Psychology and Psychiatry, 37, 89-126.

60. Bailey, A., Luthert, P., Dean, A., et al (1998) A clinicopathological study of autism. Brain, 121, 889 -905.

61. Gillian Baird and Paramala J Santosh Interface between Neurology and Psychiatry In Childhood J. Neurol. Neurosurg. Psychiatry, Mar 2003; 74: 17 -22.

62. Behbehani MM. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 1995; 46: 575-605.

63. Berney T. P. Autism; an evolving concept // The British Journal of

64. Psychiatry. 2000. - Vol. 176. - p. 20-25.

65. Bolton, P. F. & Griffiths, P. D. (1997) Association of tuberous sclerosis of temporal lobes with autism and atypical autism (comments). Lancet, 349, 392 -395.

66. Bolton, P. F., Pickles, A., Murphy, M., et al (1998) Autism, affective and other psychiatric disorders: patterns of familial aggregation. Psychological Medicine, 28, 385 -395.

67. Boullin DJ, Freeman В J, Geller E, Ritvo E, Rutter M, Yuwiler A. Toward the resolution of conflicting findings. J Autism Dev Disord 1982; 12: 97-98.

68. Bowden Charles L., Calabrese Joseph R.; Sachs Gary et al. A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder Arch Gen Psychiatry. 2003;60:392-400.

69. Brandao ML, Cardoso SH, Melo LL, Motta V, Coimbra NC. Neural substrate of defensive behavior in the midbrain tectum. Neurosci Biobehav Rev 1994; 18:339-46.

70. Campbell M, Adams P, Perry R, Spencer EK, Overall JE. Tardive and withdrawal dyskinesia in autistic children: a prospective study. Psychopharmacol Bull 1988; 24: 251-5.

71. Campbell, M., Anderson, L. Т., Small, A. M., et al (1993) Naltrexone in autistic children: behavioral symptoms and attentional learning. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1283 -1291

72. Campbell M, Fish B, Shapiro T, Floyd A. Imipramine in preschool autistic and schizophrenic children. J Autism Child Schizophr 1971; 3: 267-82.

73. Charney DS, Deutch A. A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit Rev Neurobiol 1996; 10:419-446.

74. Chez, M. & Buchanon, C. (1997) Age of regression of language and behaviour in children referred for pervasive developmental delay correlate toseverity of epileptiform activity on 24 hour EEG. Epilepsia, 38 (suppl. 3), 50.

75. Citrome L., Jaffe A., Levine L. et al. Datapoints: Use of Mood Stabilizers Among Patients With Schizophrenia, 1994-2001 // Psychiatr Serv. 2002. -Vol. 53. -P.1212

76. Cole, T. J., Freeman, J. V. & Preece, M. A. (1998) British 1990 growth reference centiles for weight, height, body mass index. Statistics in Medicine, 17, 407-429.

77. Cook EH, Rowlett R, Jaselskis C, Leventhal BL. Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry 1992; 31: 739-745.

78. Courchesne, E. (1997) Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Current Opinion in Neurobiology, 7, 269 -278

79. Cuccaro ML, Wright HH, Abramson RK, Marsteller FA, Valentine J. Whole-blood serotonin and cognitive functioning in autistic individuals and their first-degree relatives. J Neuropsychiatry Clin Neurosci 1993; 5: 94-101.

80. Cunningham MA, Pillai V, Rogers WJ Haloperidol in the treatment of children with severe behaviour disorders Br. J. Psychiatry, Jul 1968; 114: 845 854.

81. Damasio AR, Tranel D, Damasio H. Individuals with sociopathic behavior caused by frontal damage fail to respond autonomically to social stimuli. Behav Brain Res 1990; 41: 81-94.

82. Damore J, Stine J, Brody L: Medication-induced hypomania in Asperger's disorder (letter). J Am Acad Child Adolesc Psychiatry 1998;37:248-249

83. Dicks P, Myers RE, Kling A. Uncus and amygdala lesions: effects on social behavior in the free-ranging rhesus monkey. Science 1969; 165: 69-71.

84. Drummond L.M. The treatment of severe, chronic, resistant obsessive-compulsive disorder. An evaluation of an in-patient programme using behavioural psychotherapy in combination with other treatments Br. J. Psychiatry, Aug 1993; 163: 223 229.

85. Einfeld S.L. Systematic management approach to pharmacotherapy for people with learning disabilities // Advan. Psychiatr. Treat., Jan 2001; 7: 43 -49.

86. Elliott FA. Violence. The neurologic contribution: an overview. Review. Arch Neurol 1992; 49: 595-603.

87. Engel J., Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology // // Epilepsia.- 2001.- V. 42.- P. 796-803.

88. Eriksson K,. Kylliainen A., Hirvonen K. Et al. Viaual agnosia with occipital CSWS-A Landau-Kleffner equivalent? Epilepsia, V.41, Suppl. 7, 2000, p. 195

89. Ernst M, Devi L, Silva RR, Gonzalez NM, Small AM, Malone RP, Campbell M. Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children. Psychopharmacol Bull 1993; 29: 221-227.

90. D'Eufemia P, Finochiaro R, Celli M, Viozzi L, Montelenone D, Giardini O. Low serum tryptophan to large neutral amino acids ratio in idiopathic infantile autism. Biomed Pharmacother 1995; 49: 288-292.

91. Fenwick PB. Aggression and epilepsy. In: Trimble MR, Bolwig T, editors. Epilepsy and psychiatry. Chichester: John Wiley; 1986. p. 31-60.

92. Fombonne, E., Roge, В., Claverie, J., et al (1999) Microcephaly and macrocephaly in autism. Journal of Autism and Developmental Disorders, 29, 113 -119.

93. Frazier JA, Doyle R, Chiu S, Coyle JT: Treating a child with Asperger's disorder and comorbid bipolar disorder. Am J Psychiatry 2002; 159:13-21

94. Gallagher M, Chiba AA. The amygdala and emotion. Review. Curr Opin Neurobiol 1996; 6: 221-227.

95. Garcia-Flores E. Corpus Callosotomy for the Treatment of Landau-Kleffner Syndrome // Epilepsia. 1999,- V. 40.- Suppl. 2,- P. 62

96. Geller E, Yuwiler A, Freeman В J, Ritvo E. Platelet size, number, and serotonin content in blood of autistic, childhood schizophrenic, and normal children. J Autism Dev Disord 1988; 18: 119-126.

97. Ghaemi SN, Boiman EE, Goodwin FK: Kindling and second messengers: an approach to the neurobiology of recurrence in bipolar disorder. Biol Psychiatry 1999; 45:137-144

98. Ghaziuddin M, Tsai LY, Ghaziuddin N. Fluoxetine in autism: more useful in the presence of depression. J Am Acad Child Adolesc Psychiatry 1991; 30:508-509.

99. Chez, M. & Buchanon, C. (1997) Age of regression of language and behaviour in children referred for pervasive developmental delay correlate to severity of epileptiform activity on 24 hour EEG. Epilepsia, 38 (suppl. 3), 50.

100. Gillberg C. Endogenous opioid and opiate antagonists in autism: brief review of empirical findings and implications for clinicians. Dev Med Child Neurol 1995; 37: 239-245.

101. Gillberg, C. & Schaumann, H. (1983) Epilepsy presenting as infantile autism? Two case studies. Neuropediatrics, 14, 206 -212.

102. Gillberg C, Svennerholm L. CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood. Br J Psychiatry 1987; 151: 89-94.

103. Glick I.D., Suppes Т., DeBattista C. et al. Psychopharmacologic Treatment Strategies for Depression, Bipolar Disorder, and Schizophrenia. //Ann Intern Med. 2001;134:47-60.

104. Gordon CT, Rapoport JL, Hamburger SD, State RC, Mannheim GB. Differential response of seven subjects with autistic disorder to clomipramine and desipramine. Am J Psychiatry 1992; 149: 363-366.

105. Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JI. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 1993; 50: 441-447.

106. Gross-Tsur Varda and Shalev Ruth S. Reversible language regression as an adverse effect of topiramate treatment in children// Neurology, Jan 2004; 62: 299 300.

107. Guerrini R., Belmonte A., Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia. 1998. - V. 39. Suppl.3. - P. 2-10.

108. Halgren E. Emotional neurophysiology of the amygdala within the context of human cognition. In: Aggleton JP, editor. The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley-Liss; 1992. p. 191-228.

109. Hall A. Long term amphetamine treatment improved behaviour in children with attention deficit hyperactivity disorder Evid. Based Ment. Health, Aug 1998; 1:86.

110. Harrington R., Peters S., Green J. et al. Randomised comparison of the effectiveness and costs of community and hospital based mental health services for children with behavioural disorders. BMJ, Oct 2000; 321: 1047 1050.

111. Harrington R., Whittaker J., Shoebridge Ph., Campbell F. Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder BMJ, May 1998; 316: 1559 1563.

112. Hendriks M.P.H., Scholtes F.B.J. Neuropsychological Profiles of 11 Children with Continuous Spikes and Waves During Sleep (CSWS); A Clinical Follow-Up // Epilepsia. 1999. - Vol. 40, Suppl. 2. - P. 165

113. Hilty Donald M., Rodriguez Gerardo D., and HALES R.E. Treatment of Comorbid Bipolar Disorder and Epilepsy With Valproate // J. Neuropsychiatry. Clin. Neurosci., May 2000; 12: 283 285.

114. Hoshino Y, Tachibana JR, Watanabe M, Murata S, Yokoyama F, Kaneko

115. M, Yashima Y, Kumoshiro H. Serotonin metabolism and hypothalamic-pituitary function in children with infantile autism and minimal brain dysfunction. Jpn J Psychiatry Neurol 1984; 26: 937-945.

116. International Molecular Genetic Study of Autism Consortium (1998) A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Human Molecular Genetics, 7, 571 574

117. Jaselskis С A, Cook EH, Fletcher KE, Leventhal BL. Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharmacol 1992; 12: 322-327.

118. Khatami R., Grosse P., Hoffmann K.-T., Venz S., Schmitz B. Treatment of Nonconvulsive Status Epilepticus with Topiramate.// Epilepsia.- 1999.- V. 40, Suppl. 2. P. 285

119. Kling AS, Brothers LA. The amygdala and social behavior. In: Aggleton JP, editor. The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley-Liss; 1992. p. 353-377.

120. Kolmen BK, Feldman HM, Handen BL, Janosky JE. Naltrexone in young autistic children: replication study and learning measures. J Am Acad Child Adolesc Psychiatry 1997; 36: 1570-8.

121. Koshes RJ. Use of fluoxetine for obsessive-compulsive behavior in adults with autism. Am J Psychiatry 1997; 154: 578.

122. Kutschke G., Brodbeck V., Boor R., Reitter B. Do subclinical epileptic discharges (SED) influence language functions in children with developmental language disorder (DLD)? // Epilepsia. 1999.- V. 40.-Suppl. 2. P. 20

123. Launay JM, Bursztejn C, Ferrari P, Dreux C, Braconnier A, Zarifian, E,1.ncrenon S, Fermanian J. Catecholamine metabolism in infantile autism: a controlled study of 22 autistic children. J Autism Dev Disord 1987; 17: 33347.

124. LeDoux JE. Emotions: clues from the brain. Annu Rev Psychol 1995; 46: 209-235.

125. Lewine J.D., Andrews R., Chez M. et al. Magnetoencephalographic Patterns of Epileptiform Activity in Children With Regressive Autism Spectrum Disorders. Pediatrics. 1999. - Vol. 104. - P. 405-418.

126. Locascio JJ, Malone RP, Small AM, Kafantaris V, Ernst M, Lynch NS, Overall JE, Campbell M. Factors related to haloperidol response and dyskinesias in autistic children. Psychopharmacol Bull 1991; 27: 119-126.

127. Lord, C., Rutter, M. L., Goode, S., et al (1989) Autism Diagnostic Observation Schedule: a standardized observation of communicative and social behavior. Journal of Autism and Developmental Disorders, 19, 185 -212.

128. Manford M., Fish D.R., Shorvon S.D. An analysis of clinical seizure patterns and their localizing value in frontal and temporal lobe epilepsies. Brain, 1996, V. 119, P. 17-40.

129. Mattes A., Schneble H. Epilepsien. Diagnostik und Terapie fur Klinik und Praxis, Tieme Verlag Stuttgart New York, 1992.

130. McBride PA, Anderson GM, Hertzig ME, Sweeney JA, Kream J, Cohen DJ, Mann J. Serotonergic responsivity in male young adults with autistic disorder. Arch Gen Psychiatry 1989; 46: 213-221.

131. McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry 1998; 55: 633-641.

132. McEachin, J. J., Smith, T. & Lovaas, О. I. (1993) Long-term outcome for children with autism who received early intensive behavioral treatment.

133. American Journal on Mental Retardation, 97, 359 -372

134. Mehlinger R, Scheftner WA, Poznanski E. Fluoxetine and autism. J Am Acad Child Adolesc Psychiatry 1990; 29: 985.

135. Medical Economics Company. Physicians' desk reference. Montvale (NJ), Medical Economics Company; 1998.

136. Miller BL, Darby A, Benson DF, Cummings JL, Miller MH. Aggressive, and socially disruptive and antisocial behaviour associated with fronto-temporal dementia. Br J Psychiatry 1997; 170: 150-4.

137. Minderaa RB, Anderson GM, Volkmar FR, Akkerhuis GW, Cohen DJ. Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects. Biol Psychiatry 1987; 22: 93340.

138. Minderaa RB, Anderson GM, Volkmar FR, Akkerhuis GW, Cohen DJ. Neurochemical study of dopamine functioning in autistic and normal subjects. J Am Acad Child Adolesc Psychiatry 1989; 28: 190-4.

139. Minshew, N. J., Goldstein, G., Dombrowski, S. M., et al (1993) A preliminary 3IP MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Biological Psychiatry, 33, 762 -773.

140. Narayan M, Srinath S, Anderson GM, Meundi DB. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biol Psychiatry 1993; 33: 630-5.

141. Naruse H, Nagahata M, Nakane Y, Shirahashi K, Takesada M, Yamazaki K. A multi-center double-blind trial of pimozide (Orap), haloperidol and placebo in children with behavior disorders, using cross-over design. Acta Paedopsychiatr 1982; 48: 173-84.

142. Nass, R. & Petrucha, D. (1990) Acquired aphasia with convulsive disorder: a pervasive developmental disorder variant. Journal of Child Neurology, 5, 327-328.

143. Parry-Fielder В., Nolan T.M., Collins К.J., Stojcevski Z. Developmental language disorders and epilepsy // J. Paediatr. Child Hlth. 1997. - Vol. 33. - P. 277-280.

144. Perez E.R., DavidoffV., DesplandP.A. DeonnaT. Mental and behavioural deterioration of children with epilepsy and CSWS: acquired epileptic frontal syndrome // Developmental Medicine & Child Neurology. -1993.-Vol. 35.-P. 661-674.

145. Perry R, Campbell M, Adams P, Lynch N, Spencer EK, Curren EL, Overall JE. Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration. J Am Acad Child Adolesc Psychiatry 1989; 28: 87-92.

146. Picard, A., Heraut, F. C., Bouskaoui, M., et al (1998) Sleep EEG and developmental dysphasia. Developmental Medicine and Child Neurology, 40, 595 -599.

147. Plioplys, A. V. Autism: electroencephalogram abnormalities and clinical improvement with valproic acid // Archives of Pediatrics and Adolescent Medicine. 1994. - Vol. - 148. - P. 220 - 222.

148. Plesner AM, Munk-Andersen E, Luhdorf K. Epileptic aphasia and dysphoria interpreted as endogenous depression. Acta Neurol Scand 1987;76:215-218.

149. Pressler R., Robinson R.O., Wilson G.A., Binnie C.D. Treatment of interictal EEG discharges improves behaviour in children with epilepsy // Epilepsia. 2002. - Vol. 43, Suppl. 8. - P. 44.

150. Raine A, Stoddard J, Bihrle S, Buchsbaum M. Prefrontal glucose deficits in murderers lacking psychosocial deprivation. Neuropsychiatry Neuropsychol Behav Neurol 1998; 11:1-7.

151. Ramamurthi B. Stereotactic operation in behaviour disorders. Amygdalotomy and hypothalamotomy. Acta Neurochir Suppl (Wien) 1988; 44: 152-7.

152. Ramelli G.P., Donati F., Kaufmann F., Vassella F. Motor and cognitive profile during successful treatment in a case of continuous spike-waves during sleep (CSWS) // Epilepsia.- 1998.- V.39.- Suppliment 2,- P. 54.

153. Ratey J, Mikkelsen E, Sorgi P, Zuckerman S, Polakoff S, Bemporad J, Bick P, Kadish W. Autism: the treatment of aggressive behaviors. J Clin Psychopharmacol 1987; 7: 35-41.

154. Realmuto G, August G, Garfmkel B. Clinical effect of buspirone in autistic children. J Clin Psychopharmacol 1989; 9: 122-5.

155. Rolls ET. Neurophysiology and functions of the primate amygdala. In: Aggleton JP, editor. The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley-Liss; 1992. p. 143-65.

156. DF Scott and MS Schwartz EEG features of depressive and schizophrenic states The British Journal of Psychiatry 126: 408-413 (1975).

157. Shapiro AK, Shapiro E. Controlled study of pimozide vs. placebo in Tourette syndrome. J Am Acad Child Psychiatry 1984; 23: 161-73.Me

158. Scheffer I.E. Autosomal dominant rolandic epilepsy with speech dispraxia. In: Genetics of focal epilepsies: Clinical aspects and molecular biology. -2000. Berkovic S.F., Genton P., Picard F. John Libbey & Company Ltd., p.p. 109-114.

159. Schmahmann, J. D. & Sherman, J. C. (1998) The cerebellar cognitive affective syndrome. Brain, 121, 561 -579

160. Simon, E., Toll, D. & Whitehair, P. (1994) A naturalistic approach to the validation of facilitated communication. Journal of Autism and Developmental Disorders, 24, 647 -657.

161. Skuse, D. H., James, R. S., Bishop, D. V. M., et al (1997) Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature, 387, 705 -708.

162. Sobel D.F., Otsubo H., Smith M.C. Magnetoencephalography in Children with Landau-Kleffner Syndrome and Acquired Epileptic Aphasia //

163. American Journal of Neuroradiology. 2000. - Vol. 21. - P. 301- 307.

164. State R.C., Altshuler L.L., Frye M.A. Mania and Attention Deficit Hyperactivity Disorder in a Prepubertal Child: Diagnostic and Treatment Challenges. Am. J. Psychiatry, Jun 2002; 159: 918 925.

165. Stefanatos G. A., Grover W., Geller E. Case study: corticosteroid treatment of language regression in pervasive developmental disorder // Journal of the Academy of Child and Adolescent Psychiatry. 1995. - Vol. 34. - P. 1107 -1111.

166. JR Stevens and A Livermore Telemetered EEG in schizophrenia: spectral analysis during abnormal behaviour episodes // Journal of Neurology, Neurosurgery, and Psychiatry, 1982, Vol 45, 385-395.

167. Stone JL, McDaniel KD, Hughes JR, Hermann BP. Episodic dyscontrol disorder and paroxysmal EEG abnormalities: successful treatment with carbamazepine iol Psychiatry 1986; 21: 208-12.

168. Taneli B. Epileptic phenomena underlying psychiatric disorders: schizophrenic disorder, affective and anxiety disorder // Epileptologia.-2001.- V.9, Suppl. l.-P. 18-19.

169. L. Tebartz van Elst 1,2,3, F. G. Woermann2, L. Lemieux2, P. J. Thompson2 and M. R. Trimble 1, Affective aggression in patients with temporal lobe epilepsy A quantitative MRI study of the amygdala // Brain, 2000 Vol. 123, No. 2, 234-243.

170. Todd RD. Fluoxetine in autism letter. Am J Psychiatry 1991; 148: 1089.

171. ToddRD, Ciaranello RD. Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proc Natl Acad Sci USA 1985; 82: 612-6.

172. Trimble MR. Biological psychiatry. Chichester: John Wiley; 1996.

173. Tsai L. Y. Psychopharmacology in Autism // Psychosomatic Medicine. -1999.-V. 61.-P. 651-665.

174. Tuchman R. F., Rapin I. Regression in Pervasive Developmental Disorders: Seizures and Epileptiform Electroencephalogram Correlates // Pediatrics. -1997.-Vol. 99.-P. 560-566.

175. Wing, L. (1996) Wing Schedule of Handicaps, Behaviour and Skills (HBS). In Preschool Children with Inadequate Communication (ed. I. Rapin). Clinics in Developmental Medicine, no. 139. London: MacKeith Press.

176. Wycis H.T., Lee A.J., Spiegel E.A. Simultaneous records of thalamic and cortical (scalp) potentials in schizophrenics and epileptics // Conf. neurol.-1949.- V. 9.- P. 264-271.

177. Zingarelli G, Ellman G, Horn A, Wymore M, Heldon S, Chicz-DeMet A. Clinical effects of naltrexone on autistic behavior. Am J Ment Retard 1992; 97: 57-63.

178. Zuddas A, Ledda MG, Fratta A, Muglia P, Cianchetti C. Clinical effects of clozapine on autistic disorder. Am J Psychiatry 1996; 153: 738.